The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study
Open accessAbstract
AIMS: HIV-infected patients receiving combination antiretroviral therapy may experience metabolic complications, potentially increasing their risk of cardiovascular diseases (CVDs). Furthermore, exposures to some antiretroviral drugs seem to be independently associated with increased CVD risk. We aimed to develop cardiovascular risk-assessment models tailored to HIV-infected patients. METHODS AND RESULTS: Prospective multinational cohort study. The data set included 22,625 HIV-infected patients from 20 countries in Europe and Australia who were free of CVD at entry into the Data collection on Adverse Effects of Anti-HIV Drugs Study. Using cross-validation methods, separate models were developed to predict the risk of myocardial infarction, coronary heart disease, and a composite CVD endpoint. Model performance was compared with the Framingham score. The models included age, sex, systolic blood pressure, smoking status, family history of CVD, diabetes, total cholesterol, HDL cholesterol and indinavir, lopinavir/r and abacavir exposure. The models performed well with area under the receiver operator curve statistics of 0.783 (range 0.642-0.820) for myocardial infarction, 0.776 (0.670-0.818) for coronary heart disease and 0.769 (0.695-0.824) for CVD. The models estimated more accurately the outcomes in the subgroups than the Framingham score. CONCLUSION: Risk equations developed from a population of HIV-infected patients, incorporating routinely collected cardiovascular risk parameters and exposure to individual antiretroviral therapy drugs, might be more useful in estimating CVD risks in HIV-infected persons than conventional risk prediction models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While it predicts cardiovascular events, the thresholds may vary from HIV-uninfected populations and may under-estimate risk and HIV-specific indices (e.g., DAD CV index) that may be more accurate (62–64)”
From HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Office of AIDS Research by the HIV and Aging Working Group (2012) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A.-M., & Pająk, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,260
CD4+ Count–Guided Interruption of Antiretroviral Treatment
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250
Cardiovascular disease risk profiles
Anderson, K. M., Odell, P. M., Wilson, P. W. F., & Kannel, W. B. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90861-b · Cited by 2,163
D'Agostino, R. B., Grundy, S., Sullivan, L. M., Wilson, P., & for the CHD Risk Prediction Group (2001) · JAMA · doi:10.1001/jama.286.2.180 · Cited by 2,108
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
El-Sadr, W. M., & The Data Collection On Adverse Events Of Anti-HIV Drugs (DAD) Study Group (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030218 · Cited by 1,677
Self-citationTriant, V. A., Lee, H., Hadigan, C., & Grinspoon, S. K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2190 · Cited by 1,613
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521
Research works printed but not linked: 5
- Lang S, 2009, Impact of specific NRTI and PI exposure on the risk of myocardial infarction: a case-control study nested within FHDH ANRS CO4
- Benard A, 2006, Int J Tuberc Lung Dis, 10, 378
- Patel N, 2006, Clin Occup Environ Med, 5, 193
- Barrett-Connor EL, 1991, JAMA, 265, 627, 10.1001/jama.1991.03460050081025 · DOI
- Friis-Moller N, 2007, Predicting the Risk of Coronary Heart Disease in HIV-infected Patients: The D:A:D Risk Equation
Cited by
Sorted by citations
Items 301–384 of 384
Dushimiyimana, V., Twagirumukiza, M., Durand, M., Ntusi, N., Asiimwe‐Kateera, B., Bigirimana, N., Nshimiyimana, L., Ndishimye, P., Niyonkuru, V. U., Karame, P., et al. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13776-8 · Cited by 2
Stephan, C. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.734296 · Cited by 2
The significance of HIV and non-communicable diseases in Africa
Von, H. A. D., Asiimwe‐Kateera, B., White, R., & Gishoma, D. (2018) · Rwanda Journal of Medicine and Health Sciences · doi:10.4314/rjmhs.v1i1.8 · Cited by 2
Are Physical Fitness and CRP Related to Framingham Risk Score in HIV+ Adults?
Lewis, J. E., Poles, J., Garretson, E., Tiozzo, E., Goldberg, S., Campbell, C. S. G., Simões, H. G., Woolger, J. M., & Konefal, J. (2020) · American Journal of Lifestyle Medicine · doi:10.1177/1559827620904345 · Cited by 2
A cost-effectiveness analysis of E/C/F/TAF vs three boosted regimens in the Italian context
Pradelli, L., Perri, G. D., Rizzardini, G., Martelli, E., Giardina, S., & Povero, M. (2017) · Farmeconomia Health economics and therapeutic pathways · doi:10.7175/fe.v18i1.1312 · Cited by 2
Comparison of Four Predictive Scores for Cardiovascular Risk in Mexican People with HIV
Oliva-Sánchez, P. F., Landeros-López, S., Rosas-Dossetti, M. M., Grobeisen-Levin, S., Islas-Martínez, J. A., Aznar-Guerra, D., Valdez-Celiz, A. P., & Soto-Ramírez, L. E. (2024) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2023.0085 · Cited by 1
Zimba, S., Ngalamika, O., Mukambo, E., Shankanga, T., Msimuko, T., Mwansa, D., Mulenga, B., Chisha, M., Chomba, M., Asukile, M. T., et al. (2025) · AIDS Research and Therapy · doi:10.1186/s12981-025-00799-5 · Cited by 1
Tailoring cardiovascular risk prediction for people living with HIV: Evidence from Malaysia
Hwong, W. Y., Teh, H. S., Yang, S. L., Lee, J. L., Anand, S., Sim, B. L. H., Lim, Y. M. F., & Tay, K. H. (2025) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2025.108211 · Cited by 1
Cross‐sectional comparison of cardiovascular risk scores in people with HIV
Hernandez‐Pereira, M., Du, J., Soldado‐Folgado, J., Carbonell, I., Trenchs‐Rodríguez, M., González‐Mena, A., García‐Giralt, N., & Güerri‐Fernández, R. (2025) · HIV Medicine · doi:10.1111/hiv.70152 · Cited by 1
HIV Disease and the Heart: A Review
Enakpene, E. O., John, J., Obiagwu, C., Shrestha, S., Kulbak, G., Shetty, V., & Hollander, G. M. (2015) · Journal of Cardiology and Therapy · Cited by 1
Flisiak, R., Wiercińska‐Drapało, A., Bociąga‐Jasik, M., Barałkiewicz, G., Grzeszczuk, A., Olczak, A., Grąbczewska, E., Parczewski, M., Jabłonowska, E., Dąbrowska, M. M., et al. (2014) · HIV & AIDS Review · doi:10.1016/j.hivar.2014.10.002 · Cited by 1
Achhra, A. C., Amin, J., Law, M. G., Grulich, A. E., Yeung, J. Y. K., Kelleher, A. D., Cooper, D. A., & the Health In Men study group (2012) · Antiviral Therapy · doi:10.3851/imp2434 · Cited by 1
Self-citationFantauzzi, A., Floridia, M., Falasca, F., Spanedda, P., Turriziani, O., Vullo, V., & Mezzaroma, I. (2015) · PubMed · Cited by 1
Diabetes, Prediabetes, and Metabolic Syndrome Among People Living with HIV
Reddy, S. C., Moore, W. B., Rozario, P. M., & Warriner, A. H. (2019) · Springer eBooks · doi:10.1007/978-3-030-10451-1_5 · Cited by 1
CME: Dyslipidämie und kardiovaskuläres Risiko bei HIV-infizierten Patienten CME-Fragen
Tschumi, F., Brugger, S. D., & Braun, D. L. (2019) · Praxis · doi:10.1024/1661-8157/a003247 · Cited by 1
Malvestutto, C., & Aberg, J. A. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56514-5_23 · Cited by 1
Moukaïla, A. R., Mossi, E. K., Amadou, N., Némi, K. D., Kpelafia, M.-I., Tsevi, Y. M., Bawe, L. D., Djagadou, A. K., Wateba, M. I., & Djibril, A. M. (2020) · Global Journal of Medical Research · doi:10.34257/ljmhrvol20is5pg57 · Cited by 1
Parmar, A., Saha, T., Somani, B. L., & Misra, P. (2021) · Medical Journal of Dr D Y Patil Vidyapeeth · doi:10.4103/mjdrdypu.mjdrdypu_60_20 · Cited by 1
Dubé, M. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-11161-2_14 · Cited by 1
Falasca, K., Ucciferri, C., Auricchio, A., Reale, M., Costantini, E., & Vecchiet, J. (2022) · Current HIV Research · doi:10.2174/1570162x2002220623163705 · Cited by 1
PREMATURE AGING AND CARDIOVASCULAR DISEASES RELATED TO HIV INFECTION
", & Arbune, M. (2021) · Romanian Archives of Microbiology and Immunology · doi:10.54044/rami.2021.04.05 · Cited by 1
Lifestyle in people living with Human Immunodeficiency Virus: a 5 year follow-up study
Caeiro, A. P., & Policarpo, S. (2024) · Acta Portuguesa de Nutrição · doi:10.21011/apn.2024.3606 · Cited by 1
Setty, H. S. N., Natesh, B. H., Yeriswamy, M. C., Raj, V. A. S., Patil, R., Kumar, H. B. C., Shastry, L. S., Srinivas, B. C., Reddy, B., Kharge, J., et al. (2025) · Indian Heart Journal · doi:10.1016/j.ihj.2025.03.001 · Cited by 1
Cardiovascular Risk Factors Among Young People in Haiti: Implications for Low-Income Countries
Reif, L. K., Rouzier, V., Yan, L. D., Sabwa, S., Hilaire, G., Pierre, M. C. J., Riché, R. C., Peck, R. N., Ogyu, A., Sufra, R., et al. (2025) · Global Heart · doi:10.5334/gh.1435 · Cited by 1
Lipid Management in Human Immunodeficiency Virus
Myerson, M. L. (2015) · Cardiology Clinics · doi:10.1016/j.ccl.2015.01.003 · Cited by 1
Castro, G. A., León, K., Marín-Palma, D., Oyuela, S. M., Cataño-Bedoya, J. U., Duque-Botero, J., Méndez, D. P. G., Taborda, N. A., Hernández, J. C., Rugeles, M. T., et al. (2021) · Revista Ciencias de la Salud · doi:10.12804/revistas.urosario.edu.co/revsalud/a.10532 · Cited by 1
Putera, I. (2017) · Journal of HIV for Clinical and Scientific Research · doi:10.17352/2455-3786.000119 · Cited by 1
Prevalence of HIV infection in Turkey and importance of cardiovascular disease.
Korten, V. (2017) · Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · doi:10.5543/tkda.2017.40343 · Cited by 1
Limited Utility of Cardiovascular Risk Scores for People Living with HIV in MalawiPreprint
Goh, C. Y., Mwandumba, H. C., Rapala, A., Tinago, W., Sheha, I., Chammudzi, M., Mallon, P. W. G., Klein, N. J., Khoo, S., & Kelly, C. (2020) · medRxiv · doi:10.1101/2020.08.01.20166462 · Cited by 1
EFFECT OF SMOKING AND CESSATION IN HIV-INFECTED PEOPLE
Cui, Q. (2011) · MacSphere (McMaster University) · doi:10.71548/18671
Pathology of HIV/AIDS: Lessons from Autopsy Series
Bychkov, A., Yamashita, S., & Ae, D. (2011) · InTech eBooks · doi:10.5772/20103
Complications Resulting from Antiretroviral Therapy for HIV Infection
Nolan, D. A., Mallal, S. A., & Reiss, P. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-2882-6.50021-6
Self-citationInternational Congress of Drug Therapy in HIV Infection 2-6 November 2014, Glasgow, UK
(2014) · Journal of the International AIDS Society · doi:10.7448/ias.17.4.19856
What was new about vascular risk in the year 2012?
Fuentes, D. S., Fernández, C. S., Dalmau, F. G.-B., Prieto, J. M. M., Gutiérrez, P. C., & Cuende, J. I. (2013) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2013.09.001
Cornonary Heart Disease Risk and HIV Infection: The Roles of Inflammation and Co-Morbid Disease
So‐Armah, K. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Burke, E. (2012) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2012.04.003
d'Azur, C., Reboud, V., Raffi, P., Mahy, F., Roux, S., Cuzin, P., Spire, L., & Leport, C. (2012)
Khankham, S., Chularojanamontri, L., Wongpraparut, C., Silpa‐archa, N., Janyong, N., & Vathesatogkit, P. (2015) · Asian Biomedicine · doi:10.5372/1905-7415.0904.419
Was bei älteren HIV-Patienten zu beachten ist
Wolf, E., & Hammond, A. J. (2015) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-015-3163-6
UNIVERSIDADE FEDERAL DE GOIÁS PROGRAMA DE PÓS-GRADUAÇÃO EM MEDICINA TROPICAL
Pública, E. S., Ribeiro, P. M. A., & Pacheco, G. (2010)
Meta-analysis of risk prediction studies
Ahmed, I. (2015) · University of Birmingham Institutional Research Archive (University of Birmingham)
Petrilli, A. A. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.6.2015.tde-21082015-135240
How to identify HIV-infected individuals at risk for atherosclerotic events?
Boccara, F., & Cohen, A. A. (2014) · AIDS · doi:10.1097/qad.0000000000000416
Lladó, L. I. (2014) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
HIV infection and hypertension: Epidemiological and pathogenetic aspects
Manner, I. W. (2013) · NORA - Norwegian Open Research Archives
Bermúdez, E., & Patricia, J. (2015) · TDX (Tesis Doctorals en Xarxa)
Duncan, A. (2016) · Research Portal (King's College London)
Brunt, S. J. (2016) · UWA Profiles and Research Repository (University of Western Australia)
Grigioni, F., & Calza, L. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317717066
Control of hypertension in patients with and without HIV
Roever, L., Roerver-Borges, A. S., & Resende, E. S. (2017) · Internal Medicine and Care · doi:10.15761/imc.1000107
Maggi, P. (2017) · JHA - Journal of HIV and Ageing · doi:10.19198/jha31437
Decision Making Under Risk in Patients with HIV
Gilliam, S. E. (2013) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3cj87x2s
Complications resulting from antiretroviral therapy for HIV infection
Nolan, D. A., Mallal, S. A., & Reiss, P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0695-2.00014-6
Self-citationLópez-Márquez, F. C., Perez, A. A. M., Domingo, P., Robledo, A. I. U., Pérez, M. E. G., Galarza, F. F. G., Ruíz-Flores, P., & y Goytia, A. P. R. B. (2021) · Research Square · doi:10.21203/rs.3.rs-722713/v1
Pérez, A. A. M., Domingo, P., Robledo, A. I. U., Pérez, M. E. G., Galarza, F. G., Ruíz-Flores, P., y Goytia, A. P. R. B., & López-Márquez, F. C. (2022) · Research Square · doi:10.21203/rs.3.rs-1273573/v1
The prevalence of Type 2 Diabetes among people living with HIV in Georgia
Borkowska, T., Karkashadze, E., Chkhartishvili, N., Chokoshvili, O., & Tsertsvadze, T. (2022) · GEORGIAN SCIENTISTS · doi:10.52340/gs.2022.04.02.17
Myerson, M. L. (2019) · Springer eBooks · doi:10.1007/978-3-030-10451-1_2
Cardiovascular Disease, Metabolic Complications and Lipodystrophy in Persons with HIV
Pereira, L. F., Goforth, H. W., Martínez, E., Lux, J. Z., Ferrara, M., & Mullen, M. P. (2017) · doi:10.1093/med/9780199392742.003.0046
Elderly: Epidemiology of HIV/AIDS
Rao, S. G., Lambert, C., Moanna, A., & Ali, M. K. (2016) · Springer eBooks · doi:10.1007/978-1-4614-9610-6_236-1
Cavallaro, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-49687-6_28
Elderly: Epidemiology of HIV/AIDS
Rao, S. G., Lambert, C., Moanna, A., & Ali, M. K. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7101-5_236
Kirchner, J. T. (2021) · doi:10.1093/med/9780197576595.003.0045
Akinosoglou, K., Κολόσακα, Μ., Schinas, G., Delastic, A., Antonopoulou, S., Perperis, A., Marangos, M. N., Mouzaki, Α., & Gogos, C. A. (2023) · Microorganisms · doi:10.3390/microorganisms11040958
FERRAMENTAS MENSURADORAS DO RISCO CARDIOVASCULAR EM PESSOAS VIVENDO COM HIV: REVISÃO DE ESCOPO
de Vasconcelos, M. N., Lima, A. E. D. C., Vidal, E. A. P., Sousa, N. W. C., Moreira, T. M. M., & Pereira, M. L. D. (2023) · Revista de Enfermagem UFPE on line · doi:10.5205/1981-8963.2023.253773
ปจจยทสมพนธกบการเกดกลมอาการเมตาบอลกในผตดเชอเอชไอว
ทองพูล, พ. (2016) · doi:10.58837/chula.the.2016.93
Addressing atherosclerotic cardiovascular disease risk in persons with HIV
Masenga, S. K., & Woolley, I. J. (2023) · AIDS · doi:10.1097/qad.0000000000003703
HIV ile Yaşayan Bireylerin Takibinde Bütüncül Yaklaşım: Primer Kardiyovasküler Koruma
Başaran, N. Ç., & Ünal, S. (2024) · Flora the Journal of Infectious Diseases and Clinical Microbiology · doi:10.5578/flora.20249950
Girisa, S., Hegde, M., & Kunnumakkara, A. B. (2023) · Springer eBooks · doi:10.1007/978-981-19-3728-6_11 · Cited by 1
Complications resulting from antiretroviral therapy for HIV infection
Nolan, D., Mallal, S., & Reiss, P. (2012) · Pure Amsterdam UMC · doi:10.1016/b978-0-8089-2442-5.00014-6
Self-citationGálvez‐Barrón, C., Gamarra-Calvo, S., Blanco, J. R., Conde, I. S., Pérez‐López, C., Miñarro, A., & Verdejo-Muñoz, G. (2025) · Current HIV Research · doi:10.2174/011570162x373384250529110832
Quesada‐López, T., Mestres‐Arenas, A., Domingo, P., Prieto, P., Mur, I., Pérez, J. A. H., Guimarães, M. P., Villarroya, J., Gutiérrez, M. D. M., Mateo, G. M., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177996
Liu, Z., Zhang, J., Yang, X., Gao, H., Chen, S., Weissman, S., Olatosi, B., & LI, X. (2024) · Figshare · doi:10.6084/m9.figshare.25698234
Plum, P.-E., Maes, N., Sauvage, A.-S., Frippiat, F., Meuris, C., Uurlings, F., Lecomte, M., Léonard, P., Paquot, N., Fombellida, K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16575956
HIV Exacerbates Atherosclerosis by Altering Macrophage Function
Lozano-Gerona, J., Yap, J., Vanapruks, S., Irei, J. S., Bishop, T., & Boisvert, W. A. (2026) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2026.6.e18
Bellinati, P. Q., Lozovoy, M. A. B., Ahrens, T. M., Gasparetto, P. F., dos Santos, E., de Araujo, D. N. F., Alvarenga, T. M., Sakamoto, L. M., Santos, D. F. P., Fajardo, J. Z., et al. (2026) · Human Immunology · doi:10.1016/j.humimm.2026.111804
Lee, M. J., Murray, A., Smith, C. J., Abdi, Z., Duncan, A., Dwyer, E., Gompels, M., Henderson, M., Johnson, M. A., Lander, F., et al. (2026) · HIV Medicine · doi:10.1111/hiv.70282
Chan, P., Tayutivutikul, K., Slike, B. M., Pinyakorn, S., Holroyd, K. B., Sacdalan, C., Metzger, L., Promsena, P., Kroon, E., Colby, D., et al. (2026) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiag495
High cardiometabolic burden among people with HIV and obesity in Peru
Hidalgo, J. A. M., Pinedo, Y., Agurto-Lescano, E. C., Cárdenas, L. R., de la Torre, J. C. G., Ayarza, R., Valenzuela-Rodríguez, G., Rocca, J., & Rosa, A. M. L. (2026) · HIV Research & Clinical Practice · doi:10.1080/25787489.2026.2746807
Chaurasia, A. K., Dastidar, S., Gupta, P., Sachdeva, A., & Varma, S. (2026) · Journal of the Association of Physicians of India · doi:10.59556/japi.74.1708
McMahon, C. N., Blanchard, E., & Samaras, K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800769-3.00024-x
Metadata
- Authors
- Friis-Møller, N., Thiébaut, R., Reiss, P., Weber, R., D'Arminio Monforte, A., De Wit, S., El-Sadr, W., Fontas, E., Worm, S., Kirk, O., Phillips, A., Sabin, C. A., Lundgren, J. D., Law, M. G., & DAD study group
- Affiliations
- Copenhagen HIV Programme (CHIP), University of Copenhagen/Faculty of Health Science, Copenhagen, Denmark
- Inserm (FR)
- Amsterdam UMC Location University of Amsterdam (NL)
- University Hospital Zurich (CH)
- ICONA, Hospital San Paolo, University of Milan, Italy
- Saint-Pierre Cohort, CHU Saint-Pierre Hospital, Brussels, Belgium
- Columbia University Irving Medical Center (US)
- Nice Cohort, CHU Nice Hopital de l'Archet, Nice, France
- University of Copenhagen (DK)
- The Royal Free Hospital (GB)
- AHOD, National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia
- ORCID
- Venue
- European Journal of Cardiovascular Prevention & Rehabilitation
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-10
- Volume
- 17
- Issue
- 5
- Pages
- 491-501
- ISSN
- 1741-8267 (ISSN-L)
- OpenAlex
- W2160970334
- Cited by
- 384
- References
- 43
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 13 · 2023: 12 · 2022: 16 · 2021: 28 · 2020: 23 · 2019: 25 · 2018: 16 · 2017: 38 · 2016: 36 · 2015: 43 · 2014: 24 · 2013: 33 · 2012: 34
- FWCI
- 28.09
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- European Journal of Cardiovascular Prevention & Rehabilitation (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- Murdoch University Research Portal (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Science Foundation
- Bristol-Myers Squibb
- Pfizer
- GlaxoSmithKline
- Gilead Sciences
- European Commission (BIOMED2, CT94-1637, CT97-2713, QLK2-2000-00773)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (U01AI046362, U01AI042170, U01AI069907)
- Cilag
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- cardiovascular risk prediction, HIV infection, antiretroviral therapy, highly active antiretroviral therapy, metabolic complications, myocardial infarction, coronary artery disease, indinavir, lopinavir/ritonavir, abacavir, Framingham risk score, cardiovascular risk factors
- MeSH terms
- Adult, Argentina, Australia, Coronary Disease, Drug Therapy, Combination, Europe, Female, Humans, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Risk Factors, Time Factors, Reproducibility of Results, Models, Statistical, HIV Infections, Treatment Outcome, Risk Assessment, Anti-HIV Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
